Adage Capital Partners GP »

Prelude Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1M 766k 5.33

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)

View all positions for Adage Capital Partners GP

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
RA Capital Management
Soleus Capital Management
Kynam Capital Management
Vanguard Capital Management
BlackRock
Sphera Funds Management
Two Sigma Investments
ADAR1 Capital Management
Millennium Management
Geode Capital Management
Adage Capital Partners GP
Acadian Asset Management
Morgan Stanley

View all funds holding Prelude Therapeutics